• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大阿片类药物使用障碍药物的可及性:退伍军人健康管理局以外的项目与政策方法

Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration.

作者信息

Priest Kelsey C, McCarty Dennis, Lovejoy Travis I

机构信息

School of Medicine, MD/PhD Program, Oregon Health & Science University, Portland, OR, USA.

School of Public Health, Oregon Health & Science University-Portland State University, Portland, OR, USA.

出版信息

J Gen Intern Med. 2020 Dec;35(Suppl 3):886-890. doi: 10.1007/s11606-020-06266-3. Epub 2020 Nov 3.

DOI:10.1007/s11606-020-06266-3
PMID:33145685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7609303/
Abstract

To mitigate morbidity and mortality of the drug-related overdose crisis, the Veterans Health Administration (VHA) can increase access to treatments that save lives-medications for opioid use disorder (MOUD). Despite an increasing need, MOUD continues to be underutilized due to multifaceted barriers that exist within broader macro- and microenvironments. To promote MOUD utilization, policymakers and healthcare leaders should (1) identify and implement person-centered MOUD delivery systems (e.g., the Medication First Model, community-informed design); (2) recognize and address MOUD delivery gaps (e.g., the Best-Practice in Oral Opioid Agonist Collaborative); (3) broaden the definition of the MOUD delivery system (e.g., access to MOUD in non-clinical settings); and (4) expand MOUD options (e.g., injectable opioid agonist therapy). Increasing access to MOUD is not a singular fix to the overdose-related crisis. It is, however, a possible first step to mitigate harm, and save lives.

摘要

为降低与药物相关的过量用药危机的发病率和死亡率,退伍军人健康管理局(VHA)可增加获得挽救生命的治疗方法——阿片类药物使用障碍药物(MOUD)的机会。尽管需求不断增加,但由于更广泛的宏观和微观环境中存在多方面障碍,MOUD的使用仍未得到充分利用。为促进MOUD的使用,政策制定者和医疗保健领导者应:(1)确定并实施以患者为中心的MOUD给药系统(例如,药物优先模式、社区知情设计);(2)认识并解决MOUD给药差距(例如,口服阿片类激动剂协作的最佳实践);(3)拓宽MOUD给药系统的定义(例如,在非临床环境中获得MOUD);以及(4)扩大MOUD选项(例如,注射用阿片类激动剂疗法)。增加获得MOUD的机会并非解决过量用药相关危机的唯一办法。然而,这可能是减轻伤害和挽救生命的第一步。

相似文献

1
Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration.扩大阿片类药物使用障碍药物的可及性:退伍军人健康管理局以外的项目与政策方法
J Gen Intern Med. 2020 Dec;35(Suppl 3):886-890. doi: 10.1007/s11606-020-06266-3. Epub 2020 Nov 3.
2
Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.阶梯式阿片类药物使用障碍治疗培训师计划(SCOUTT):在退伍军人健康管理局设施内扩大阿片类药物使用障碍药物治疗的获取途径。
Subst Abus. 2020;41(3):275-282. doi: 10.1080/08897077.2020.1787299.
3
Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities.农村与城市退伍军人事务部医疗机构中阿片类药物使用障碍药物的可及性。
J Gen Intern Med. 2023 Jun;38(8):1871-1876. doi: 10.1007/s11606-023-08027-4. Epub 2023 Jan 23.
4
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.COVID-19 的影响以及快速放宽政策以扩大阿片类药物使用障碍(MOUD)药物获取:一项全国退伍军人健康管理局队列研究。
Drug Alcohol Depend. 2022 Dec 1;241:109678. doi: 10.1016/j.drugalcdep.2022.109678. Epub 2022 Nov 1.
5
Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application.支付相关的阿片类药物使用障碍治疗障碍:文献综述及真实世界应用的批判性评价。
J Subst Use Addict Treat. 2024 Oct;165:209441. doi: 10.1016/j.josat.2024.209441. Epub 2024 Jun 19.
6
A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.一项针对 Veterans Health Administration 中涉及法律问题的退伍军人中阿片类药物使用障碍药物治疗的障碍和促进因素的全国性调查。
Subst Abus. 2022;43(1):556-563. doi: 10.1080/08897077.2021.1975867. Epub 2021 Sep 29.
7
From policy to practice: Pilot program increases access to medication for opioid use disorder in rural Colorado.从政策到实践:试点项目增加了科罗拉多州农村地区阿片类药物使用障碍患者的药物可及性。
J Subst Abuse Treat. 2020 Jul;114:108027. doi: 10.1016/j.jsat.2020.108027. Epub 2020 May 7.
8
Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs.在公立药物滥用治疗项目中实施和评估密苏里州的药物优先治疗阿片类药物使用障碍的方法。
J Subst Abuse Treat. 2020 Jan;108:55-64. doi: 10.1016/j.jsat.2019.06.015. Epub 2019 Jun 26.
9
Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C.扩大阿片类药物使用障碍治疗药物获取的法律:对 16 个州和华盛顿哥伦比亚特区的法律分析
Am J Drug Alcohol Abuse. 2022 Jul 4;48(4):492-503. doi: 10.1080/00952990.2022.2082301. Epub 2022 Jun 30.
10
Drug court utilization of medications for opioid use disorder in high opioid mortality communities.高阿片类死亡率社区药物法庭对治疗阿片类药物使用障碍药物的使用情况。
J Subst Abuse Treat. 2022 Oct;141:108850. doi: 10.1016/j.jsat.2022.108850. Epub 2022 Jul 29.

引用本文的文献

1
Factors associated with medications for opioid use disorder (MOUD) treatment success during the pregnancy and postpartum periods: A scoping review.与孕期和产后期间阿片类药物使用障碍(MOUD)治疗成功相关的因素:范围综述。
Drug Alcohol Depend. 2024 Nov 1;264:112454. doi: 10.1016/j.drugalcdep.2024.112454. Epub 2024 Sep 28.
2
Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical Trial.社区治疗康复干预对持照美沙酮开方医生和美沙酮处方的影响:HC 随机临床试验的预先指定二次分析。
JAMA Netw Open. 2024 Feb 5;7(2):e240132. doi: 10.1001/jamanetworkopen.2024.0132.
3
Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic.在 COVID-19 大流行期间,患有共病性阿片类药物使用障碍和慢性疼痛的患者接受阿片类药物使用障碍药物治疗的利用情况和差异。
Drug Alcohol Depend. 2023 Dec 1;253:111023. doi: 10.1016/j.drugalcdep.2023.111023. Epub 2023 Nov 11.
4
Access to medication for opioid use disorder supported by telemedicine and healthcare coverage: A web-based survey during the COVID-19 pandemic.远程医疗和医保支持下的阿片类物质使用障碍药物获取情况:新冠疫情期间的一项网络调查
Addict Behav Rep. 2023 Sep 9;18:100515. doi: 10.1016/j.abrep.2023.100515. eCollection 2023 Dec.
5
Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation.临床医生在 COVID-19 大流行期间提供阿片类药物使用障碍药物治疗的观点:定性评估。
J Addict Med. 2023;17(4):e262-e268. doi: 10.1097/ADM.0000000000001156. Epub 2023 Mar 2.
6
The introduction of a novel formulation of buprenorphine into organized health systems.将丁丙诺啡的一种新型制剂引入有组织的卫生系统。
Drug Alcohol Depend Rep. 2022 Aug 12;4:100090. doi: 10.1016/j.dadr.2022.100090. eCollection 2022 Sep.
7
Characterization of Unintentional Deaths Among Buprenorphine Users.海洛因成瘾者意外死亡特征分析
J Stud Alcohol Drugs. 2023 Jan;84(1):171-179. doi: 10.15288/jsad.22-00049.
8
Medication Use Evaluation of High-Dose Long-Term Opioid De-prescribing in Multiple Veterans Affairs Medical Centers.多所退伍军人事务医疗中心的高剂量长期阿片类药物减用评估。
J Gen Intern Med. 2022 Dec;37(16):4037-4046. doi: 10.1007/s11606-022-07807-8. Epub 2022 Oct 11.
9
Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.阿片类激动剂治疗与注射吸毒相关的细菌和真菌感染后死亡或再入院的风险:来自澳大利亚新南威尔士州的队列研究。
PLoS Med. 2022 Jul 19;19(7):e1004049. doi: 10.1371/journal.pmed.1004049. eCollection 2022 Jul.
10
U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts.美国退伍军人与阿片类药物过量危机:风险因素和预防工作的回顾。
Ann Med. 2022 Dec;54(1):1826-1838. doi: 10.1080/07853890.2022.2092896.

本文引用的文献

1
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.改善阿片类物质使用障碍患者获得循证医学治疗的途径:应对治疗系统中关键障碍的策略
NAM Perspect. 2020 Apr 27;2020. doi: 10.31478/202004b. eCollection 2020.
2
Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.阶梯式阿片类药物使用障碍治疗培训师计划(SCOUTT):在退伍军人健康管理局设施内扩大阿片类药物使用障碍药物治疗的获取途径。
Subst Abus. 2020;41(3):275-282. doi: 10.1080/08897077.2020.1787299.
3
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report.COVID-19 时期的低障碍远程丁丙诺啡治疗:病例报告。
J Addict Med. 2020 Jul/Aug;14(4):e136-e138. doi: 10.1097/ADM.0000000000000682.
4
Innovation During COVID-19: Improving Addiction Treatment Access.新冠疫情期间的创新:改善成瘾治疗的可及性。
J Addict Med. 2020 Jul/Aug;14(4):e8-e9. doi: 10.1097/ADM.0000000000000685.
5
Mobile, Community-Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study.基于移动的、面向社区的美沙酮治疗方案治疗有阿片类物质使用障碍的经历 homelessness 的退伍军人:一项试点、可行性研究。
Am J Addict. 2020 Nov;29(6):485-491. doi: 10.1111/ajad.13055. Epub 2020 May 4.
6
Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis.退伍军人事务部住院期间阿片类激动剂治疗:一项实用的回顾性队列分析。
J Gen Intern Med. 2020 Aug;35(8):2365-2374. doi: 10.1007/s11606-020-05815-0. Epub 2020 Apr 14.
7
Stigma as a fundamental hindrance to the United States opioid overdose crisis response.污名化是美国阿片类药物过量危机应对的根本障碍。
PLoS Med. 2019 Nov 26;16(11):e1002969. doi: 10.1371/journal.pmed.1002969. eCollection 2019 Nov.
8
Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic.患者对治疗物质使用障碍的过渡性、低门槛诊所的体验:桥诊的定性研究。
J Subst Abuse Treat. 2019 Dec;107:1-7. doi: 10.1016/j.jsat.2019.09.003. Epub 2019 Sep 10.
9
Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.用于阿片类物质使用障碍的注射用阿片类激动剂治疗:一项国家临床指南。
CMAJ. 2019 Sep 23;191(38):E1049-E1056. doi: 10.1503/cmaj.190344.
10
Implementation of a regional quality improvement collaborative to improve care of people living with opioid use disorder in a Canadian setting.在加拿大,实施区域质量改进合作,以改善阿片类药物使用障碍患者的护理。
BMC Health Serv Res. 2019 Sep 14;19(1):663. doi: 10.1186/s12913-019-4472-8.